相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Bryce B. Reeve et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
A new index of priority symptoms in advanced ovarian cancer
Sally E. Jensen et al.
GYNECOLOGIC ONCOLOGY (2011)
A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study
Vivian E. von Gruenigen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): Searching for Standards
Charles S. Cleeland et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Assessment of Factors That Contribute to Decreased Quality of Life in Gynecologic Oncology Group Ovarian Cancer Trials
Vivian E. von Gruenigen et al.
CANCER (2009)
Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer
Ernest S. Han et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2009)
A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer
Kathleen M. Schmeler et al.
GYNECOLOGIC ONCOLOGY (2009)
Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study
Lani Wenzel et al.
GYNECOLOGIC ONCOLOGY (2008)
Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: Results of a phase III study of the North-Eastern German Society of Gynecological Oncology ovarian cancer study group
Jalid Sehouli et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evaluation of the Symptom Representation Questionnaire (SRQ) for assessing cancer-related symptoms
Heidi Scharf Donovan et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
A phase 1 study of MORAb-009, a monoclonal antibody against mesothelin in pancreatic cancer, mesothelioma and ovarian adenocarcinoma
D. K. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: A phase II trial
David M. Kushner et al.
GYNECOLOGIC ONCOLOGY (2007)
Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: A Gynecologic Oncology Group study
Lari B. Wenzel et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A Phase II trial of oral capecitabine in patients with platinum and taxane refractory ovarian, fallopian tube, or peritoneal cancer
Judith K. Wolf et al.
GYNECOLOGIC ONCOLOGY (2006)
A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinurn containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study
H. Hirte et al.
GYNECOLOGIC ONCOLOGY (2006)
Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy
Janet S. de Moor et al.
PSYCHOSOMATIC MEDICINE (2006)
Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel
ER Greimel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Standard treatment in advanced ovarian cancer in 2005: the state of the art
MA Bookman
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer
HS Donovan et al.
GYNECOLOGIC ONCOLOGY (2005)
Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: A Gynecologic Oncology Group Study
L Wenzel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer
CC Sun et al.
SUPPORTIVE CARE IN CANCER (2005)
Quality of life in ovarian cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study
A Bezjak et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Frequency of symptoms of ovarian cancer in women presenting to primary care clinics
BA Goff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy
EA Calhoun et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer
E Greimel et al.
EUROPEAN JOURNAL OF CANCER (2003)
Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A prospective longitudinal study
YM Chan et al.
GYNECOLOGIC ONCOLOGY (2003)
Quality of life in ovarian cancer patients receiving chemotherapy
CM Lakusta et al.
GYNECOLOGIC ONCOLOGY (2001)
Reliability and validity of the functional assessment of cancer therapy-ovarian
K Basen-Engquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer
C Doyle et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report
A Cull et al.
EUROPEAN JOURNAL OF CANCER (2001)
分享论文
